[Hypomagnesemic and hypocalcemic coma, convulsions and ocular motility disorders after chemotherapy with platinum compounds]

Rev Med Interne. 1996;17(6):467-9. doi: 10.1016/0248-8663(96)86439-3.
[Article in French]

Abstract

We describe a case of neurologic manifestations including coma, convulsion and eye movement disorders, associated with hypomagnesemia and hypocalcemia in a patient treated with cisplatin for an ovarian adenocarcinoma. Pathophysiological mechanisms involve renal tubular damage leading to renal magnesium wasting and related hypocalcemia.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Adenocarcinoma / drug therapy
  • Antineoplastic Agents / adverse effects*
  • Carboplatin / adverse effects*
  • Cisplatin / adverse effects*
  • Coma / chemically induced
  • Female
  • Humans
  • Hypocalcemia / chemically induced*
  • Magnesium / blood*
  • Middle Aged
  • Ocular Motility Disorders / chemically induced
  • Ovarian Neoplasms / drug therapy
  • Seizures / chemically induced

Substances

  • Antineoplastic Agents
  • Carboplatin
  • Magnesium
  • Cisplatin